Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome

Ann Hematol. 2023 Sep;102(9):2633-2634. doi: 10.1007/s00277-023-05335-x. Epub 2023 Jun 26.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Pancytopenia* / drug therapy
  • Pancytopenia* / etiology
  • Sepsis* / complications
  • Sepsis* / drug therapy
  • Syndrome

Substances

  • tocilizumab
  • Antibodies, Monoclonal, Humanized